A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB

NCT02333799 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: Bedaquiline
DRUG: PA-824
DRUG: Linezolid

Sponsor

Global Alliance for TB Drug Development